Amgen Webcast Investor Meeting at Upcoming American Heart Association

Now one of our industry peers—Amgen, according to the Market Capitalization in Q2 of 2012 rank, is the top 2/25 biotechnology companies, the world largest independent biotechnology firm, On Nov. 1, announced it will host a webcast investor meeting at the American Heart Association (AHA) Scientific Sessions 2012 on Tuesday, Nov. 6, at 7:00 p.m. Pacific Standard Time. Its executive vice president of R&D and clinical staff will participate in the meeting to talk about the topics will being presented at AHA.

The live audio of the meeting will be then online for news media, investors and general public. Amgen, Thousand Oaks